Prognostic Significance of Silent Myocardial Infarction in Newly Diagnosed Type 2 Diabetes Mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Circulation

• Publication date

  2013-01-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.112.000908PMID 23362315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes

  2011cited by this paper
• Long-term effects of intensive glucose lowering on cardiovascular outcomes.

  2011cited by this paper
• Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

  2011cited by this paper
• Current noninvasive imaging techniques for detection of coronary artery disease

  2010cited by this paper
• Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

  2010influential reference
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients

  2008cited by this paper
• A cardiac magnetic resonance imaging study of electrocardiographic Q waves in type 2 diabetes: the Fremantle Diabetes Study.

  2008influential reference
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Screening for Coronary Artery Disease in Patients With Diabetes

  2008cited by this paper
• Screening for Coronary Artery Disease in Patients With Diabetes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

  2007cited by this paper
• The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women

  2006cited by this paper
• Lack of sensitivity of the electrocardiogram for detection of old myocardial infarction: a cardiac magnetic resonance imaging study.

  2006cited by this paper
• The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more.

  2006cited by this paper
• UK prospective diabetes study (UKPDS)

  2004cited by this paper
• Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study

  2004cited by this paper
• The accuracy of electrocardiographic Q waves for the detection of prior myocardial infarction as assessed by a novel standard of reference

  2004cited by this paper
• The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

  2001cited by this paper
• Can the surface electrocardiogram be used to predict myocardial viability?

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Natural history of isolated bundle branch block.

  1996cited by this paper
• Unrecognized Myocardial Infarction: Epidemiology, Clinical Characteristics, and the Prognostic Role of Angina Pectoris: The Reykjavik Study

  1995cited by this paper
• UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

  1991cited by this paper
• Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study.

  1990cited by this paper
• Resting electrocardiographic abnormalities suggestive of asymptomatic ischemic heart disease associated with non-insulin-dependent diabetes mellitus in a defined population.

  1990cited by this paper
• The incidence and prognosis of unrecognized myocardial infarction.

  1990cited by this paper
• The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program.

  1989cited by this paper
• Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population.

  1989influential reference
• Regression of Q waves following acute myocardial infarction.

  1989cited by this paper
• Unrecognized myocardial infarction and hypertension: the Framingham Study.

  1985cited by this paper
• Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study.

  1984cited by this paper
• Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors.

  1976cited by this paper
• Reproducibility of analysis of the electrocardiogram in epidemiology using the 'Minnesota code'.

  1970cited by this paper
• Clinically unrecognized myocardial infarction in the Western Collaborative Group Study.

  1967cited by this paper

• 6. CARDIO-RENAL PROTECTION IN TYPE 2 DIABETES.

  2025cites this paper
• Electrocardiographic criteria for silent myocardial infarction: Impact of different definitions on detection rates and prognostic significance in the atherosclerosis risk in communities (ARIC) study: A comparison with evolving bundle branch blocks.

  2025cites this paper
• Semaglutide Therapy and Cardiorenal Risk Management in Type 2 Diabetes: hsCRP as a Biomarker of Risk

  2025cites this paper
• Correlation of COVID-19 and development of new onset diabetes mellitus and its possible pathogenesis

  2025cites this paper
• The role of clinical pharmacists in improving diabetic care of hospitalized heart patients

  2024cites this paper
• Faut-il dépister l’ischémie myocardique silencieuse des patients diabétiques ?

  2024cites this paper
• Deciphering Oxidative Stress in Cardiovascular Disease Progression: A Blueprint for Mechanistic Understanding and Therapeutic Innovation

  2024cites this paper
• Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease—A Narrative Clinical Review

  2024cites this paper
• Clinical evolution of COVID-19 patients with hypertension and/or diabetes in the intensive care units: a systematic review

  2023cites this paper
• Cardiac Autonomic Dysfunction and Risk of Silent Myocardial Infarction Among Adults With Type 2 Diabetes

  2023cites this paper
• Prognostic implications of unrecognized myocardial infarction and periprocedural myocardial injury on cardiac magnetic resonance imaging in patients with chronic coronary syndrome

  2023cites this paper
• Silent myocardial infarction fatty scars detected by coronary calcium score CT scan in diabetic patients without history of coronary heart disease

  2023cites this paper
• Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz (Update 2023)

  2023cites this paper
• Relation of glycemic status with unrecognized MI and the subsequent risk of mortality: The Jackson Heart Study

  2022cites this paper
• Role of High-Sensitivity C-reactive Protein (Hs-CRP) in Non-communicable Diseases: A Review

  2022cites this paper
• Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes

  2022cites this paper
• Examination of New Electrocardiographic Repolarization Markers in Diabetic Patients with Noncritical Coronary Artery Disease

  2022cites this paper
• The utility of silent myocardial infarction on electrocardiogram as an ASCVD risk enhancer for primary prevention: The multi-ethnic study of atherosclerosis.

  2021cites this paper
• MIKB: A manually curated and comprehensive knowledge base for myocardial infarction

  2021cites this paper
• Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes

  2021cites this paper
• Analysis of the Results of Cardiovascular Disease Risk Assessment Program

  2021cites this paper
• Type 2 Diabetes and Causes of Sudden Cardiac Death: A Systematic Review

  2021cites this paper
• Understanding the place for GLP‐1RA therapy: Translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selection

  2021cites this paper
• Diabetic dyslipidaemia

  2021cites this paper
• Risk of Silent Myocardial Infarction in Prediabetic Patients: A Case-Control Study in a Veteran Population

  2021cites this paper
• Diabetic microvascular complications are associated with reduced global longitudinal strain independent of atherosclerotic coronary artery disease in asymptomatic patients with diabetes mellitus: a cross-sectional study

  2021cites this paper
• Acute coronary syndrome in diabetes mellitus: features of pathogenesis, course and therapy

  2021cites this paper
• Risk factors of the development of vascular and neuropathic complications in patients with type 2 diabetes mellitus and autoimmune thyroiditis

  2021cites this paper
• Hinokinin alleviates high fat diet/streptozotocin-induced cardiac injury in mice through modulation in oxidative stress, inflammation and apoptosis.

  2021cites this paper
• Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention.

  2021cites this paper
• Silent coronary artery disease in type 2 diabetes: a narrative review on epidemiology, risk factors, and clinical studies

  2021cites this paper
• Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study

  2020cites this paper
• Association Between Silent Myocardial Infarction and Long‐Term Risk of Sudden Cardiac Death

  2020cites this paper
• Prevalence of ECG abnormalities in people with type 2 diabetes: The Hoorn Diabetes Care System cohort.

  2020cites this paper
• Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration

  2020cites this paper
• Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis

  2020cites this paper
• Association of Silent Myocardial Infarction With Major Cardiovascular Events in Diabetes: The ACCORD Trial

  2020cites this paper
• Impact of the Location of ST-T Abnormalities Accompanying Minor Q-Waves on the Definition of Prior Myocardial Infarction.

  2019cites this paper
• Silent myocardial infarction and risk of heart failure: Current evidence and gaps in knowledge.

  2019cites this paper
• One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.

  2019cites this paper
• The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes

  2019cites this paper
• Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz (Update 2019)

  2019cites this paper
• Electrocardiographic definition of silent myocardial infarction in population studies: A call to standardize the standards.

  2019cites this paper
• Interfering with long chain noncoding RNA ANRIL expression reduces heart failure in rats with diabetes by inhibiting myocardial oxidative stress

  2019cites this paper
• Diabetes Mellitus: An Independent Risk Factor of In-Hospital Mortality in Patients with Infective Endocarditis in a New Era of Clinical Practice

  2019cites this paper
• Electrocardiographic definition of silent myocardial infarction in population studies: A call to standardize the standards.

  2019cites this paper
• Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study

  2019cites this paper
• Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

  2018cites this paper
• Abnormal Fasting Glucose Increases Risk of Unrecognized Myocardial Infarctions in an Elderly Cohort

  2018cites this paper
• Value of Estimated Glomerular Filtration Rate and Albuminuria in Predicting Cardiovascular Risk in Patients with Type 2 Diabetes without Cardiovascular Disease

  2018cites this paper
• A retrospective analysis of electrocardiographic abnormalities found in black South African patients with diabetes attending a regional hospital in KwaZulu-Natal

  2018cites this paper
• Silent Myocardial Infarction: Listen to the Evidence.

  2018cites this paper
• Evolution of silent myocardial ischaemia prevalence and cardiovascular disease risk factor management in Type 2 diabetes over a 10‐year period: an observational study

  2017cites this paper
• Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM)

  2017cites this paper
• The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.

  2017cites this paper
• The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction

  2017cites this paper
• Prevalencia de cardiopatía isquémica asintomática en pacientes con diabetes mellitus tipo 2

  2017cites this paper
• Postprandial Blood Glucose Outweighs Fasting Blood Glucose and HbA1c in screening Coronary Heart Disease

  2017cites this paper
• Hemoglobin A1c is associated with severity of coronary artery stenosis but not with long term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplasty

  2017cites this paper
• Treat the patient, not the machine...always true? A case report of silent myocardial infarction.

  2017cites this paper
• Syddansk Universitet The interplay between fasting glucose , echocardiography , and biomarkers Pathophysiological considerations and prognostic implications

  2017cites this paper
• Silent coronary heart disease in patients with type 2 diabetes: application of a screening approach in a follow-up study.

  2017cites this paper
• Predictors of electrocardiographic abnormalities in type 1 Diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy

  2017cites this paper
• Prognostic value of silent myocardial infarction in patients with chronic kidney disease being evaluated for kidney transplantation.

  2017cites this paper
• Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome

  2017cites this paper
• Assessing Cardiovascular Risk and Testing in Type 2 Diabetes

  2017cites this paper
• Relation Between Erectile Dysfunction and Silent Myocardial Ischemia in Diabetic Patients: A Multidetector Computed Tomographic Coronary Angiographic Study

  2016cites this paper
• A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes

  2016cites this paper
• Association of cardiovascular disease risk factors with left ventricular mass, biventricular function, and the presence of silent myocardial infarction on cardiac MRI in an asymptomatic population

  2016cites this paper
• A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes

  2016cites this paper
• Coronary Atherosclerosis: Pathophysiologic Basis for Diagnosis and Management.

  2016cites this paper
• Management of Cardiovascular Risk Factors in Type 2 Diabetes Mellitus Patients

  2016cites this paper
• Erratum to: Association of cardiovascular disease risk factors with left ventricular mass, biventricular function, and the presence of silent myocardial infarction on cardiac MRI in an asymptomatic population

  2016cites this paper
• Impact of Stress Testing for Coronary Artery Disease Screening in Asymptomatic Patients With Diabetes Mellitus: A Community-Based Study in Olmsted County, Minnesota.

  2016cites this paper
• Koronare Herzerkrankung bei Diabetes mellitus

  2016cites this paper
• Diabetes Dyslipidemia

  2016cites this paper
• Значение гипергликемии в остром периоде инфаркта миокарда: результаты клинического исследования

  2015cites this paper
• Integrated cardiac magnetic resonance imaging with coronary magnetic resonance angiography, stress-perfusion, and delayed-enhancement imaging for the detection of occult coronary artery disease in asymptomatic individuals

  2015cites this paper
• Assessment of subclinical cardiac changes in structure and function by cardiovascular magnetic resonance

  2015influential citation
• Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

  2015cites this paper
• Risk stratification of diabetics with stress testing: can we do better?

  2015cites this paper
• AHA/ADA Scientific Statement

  2015cites this paper
• Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association

  2015cites this paper
• Cardiovascular disease among women with and without diabetes mellitus and bilateral oophorectomy.

  2015cites this paper
• Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation; results of greater than a decade follow-up.

  2015cites this paper
• Prediabetes and the association with unrecognized myocardial infarction in the multi-ethnic study of atherosclerosis.

  2015cites this paper
• The Changes of Biomarkers by Telmisartan and their Significance in Cardiovascular Outcomes: Design of a Trial of Telmisartan Prevention ofCardiovascular Diseases (ATTEMPT-CVD)

  2014cites this paper
• Recent Medical Treatment of Diabetes Mellitus : Prevention and Cardiovascular Complications

  2014cites this paper
• EFFICIENCY AND SAFETY OF THE ORAL HYPOGLYCAEMIC AGENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR DISEASES

  2014cites this paper
• Diabetes, Pre-Diabetes and Incidence of Subclinical Myocardial Damage

  2014cites this paper
• Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease: Prospective Observational Multicenter Study

  2014cites this paper
• Management of Stable Angina in Patients with Type 2 Diabetes Mellitus

  2014cites this paper
• Diabetes Mellitus, Prediabetes, and Incidence of Subclinical Myocardial Damage

  2014cites this paper
• Short-Term Outcome of Discharged Low-Risk Chest Pain without Provoke Ischemia Study

  2014cites this paper
• Electrocardiographic identification of prior myocardial infarction during right ventricular pacing--effect of septal versus apical pacing.

  2014cites this paper
• Reperfusion therapy for ST-segment elevation myocardial infarction: has ECG information been underutilized?

  2014cites this paper
• Coronary artery plaque volume and obesity in patients with diabetes: the factor-64 study.

  2014cites this paper
• Reclassification of cardiovascular risk by myocardial perfusion imaging in diabetic patients with abnormal resting electrocardiogram.

  2014cites this paper
• Optimal treatment of chronic angina in patients with type 2 diabetes mellitus

  2014cites this paper
• Interaction network analysis revealed biomarkers in myocardial infarction

  2014cites this paper